Trial Profile
Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for stage II-IIIA non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 May 2021
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 21 May 2021 Status changed from active, no longer recruiting to completed.
- 23 Feb 2021 Status changed from recruiting to active, no longer recruiting.
- 15 Jan 2015 New trial record